The discovery of an arylsulfone hydroxamic acid template for the inhibition of phosphodiesterase type 4 and matrix metalloproteinases.

被引：0
|
作者：
Groneberg, RD [1 ]
Burns, CJ [1 ]
Condon, SM [1 ]
McGeehan, GM [1 ]
Ulrich, JW [1 ]
Morrissette, MM [1 ]
Morris, RL [1 ]
Djuric, SW [1 ]
机构：
[1] Rhone Poulenc Rorer, Collegeville, PA 19426 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 216卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
001-MEDI
引用
收藏
页码：U201 / U201
页数：1
相关论文
共 50 条
  • [1] Dual inhibition of phosphodiesterase 4 and matrix metalloproteinases by an (arylsulfonyl)hydroxamic acid template
    Groneberg, RD
    Burns, CJ
    Morrissette, MM
    Ullrich, JW
    Morris, RL
    Darnbrough, S
    Djuric, SW
    Condon, SM
    McGeehan, GM
    Labaudiniere, R
    Neuenschwander, K
    Scotese, AC
    Kline, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (04) : 541 - 544
  • [2] Inhibition of matrix metalloproteinases.
    Hagmann, WK
    Lark, MW
    Becker, JW
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 : 231 - 240
  • [3] The discovery of potent, achiral inhibitors of matrix metalloproteinases.
    Pikul, S
    Almstead, NG
    De, B
    Dunham, KLM
    Natchus, MG
    Snider, CE
    Okhamafe, A
    Taiwo, YO
    Mieling, GE
    Gu, F
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1157 - U1157
  • [4] The discovery of phosphinamide-based inhibitors of matrix metalloproteinases.
    Pikul, S
    Almstead, NG
    De, B
    Dunham, KLM
    Natchus, MG
    Snider, CE
    Taiwo, YO
    Chen, LY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U862 - U862
  • [5] Development of a series of sulfone retrohydroxamates for the inhibition of matrix metalloproteinases.
    Stacey, JR
    Wada, CK
    Michaelides, M
    Davidsen, SK
    Elmore, I
    Marcotte, P
    Morgan, D
    Albert, D
    Bouska, J
    Goodfellow, C
    Tapang, P
    Magoc, T
    Garland, R
    Guo, Y
    Dai, YJ
    Holms, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U546 - U546
  • [6] Dual inhibitors of phosphodiesterase type 4 and matrix metalloproteinases
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1999, 4 (06) : 290 - 291
  • [7] INHIBITION OF MATRIX METALLOPROTEINASES BY PEPTIDYL HYDROXAMIC ACIDS
    ODAKE, S
    MORITA, Y
    MORIKAWA, T
    YOSHIDA, N
    HORI, H
    NAGAI, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (03) : 1442 - 1446
  • [8] Attenuation of anti-Thy1.1 nephritis by inhibition of matrix metalloproteinases.
    SteinmannNiggli, K
    Marti, HP
    KIDNEY INTERNATIONAL, 1997, 52 (05) : 1425 - 1426
  • [9] Chronic allograft nephropathy during early and late inhibition of matrix metalloproteinases.
    Lutz, J
    Ouyang, N
    Yao, YS
    Liu, SY
    Heemann, U
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 557A - 558A
  • [10] Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases
    Levin, JI
    Gu, YS
    Nelson, FC
    Zask, A
    DiJoseph, JF
    Sharr, MA
    Sung, A
    Jin, GX
    Cowling, R
    Chanda, P
    Cosmi, S
    Hsiao, CL
    Edris, W
    Wilhelm, J
    Killar, LM
    Skotnicki, JS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (02) : 239 - 242
12345